Qinhao Pharma Hong Kong IPO Prospectus Expires on July 16, 2026
According to Zhitong Finance, Qinhao Pharma (Suzhou) Co., Ltd.'s Hong Kong IPO prospectus, filed on January 16, 2026, expired on July 16, 2026, after reaching the six-month validity period. Huatai International served as the sole sponsor for the offering.
Qinhao Pharma is a biopharmaceutical
GateNews·07-15 22:31
